Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryogo Minamimoto

Showing results (21-30 of 148) with videos related to

Pageof 15
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2016
Bombesin-Targeted PET of Prostate CancerRosalba Mansi, Ryogo Minamimoto, Helmut Mäcke, et al.
Clinical Nuclear Medicine|July 24, 2020
Nivolumab-Induced Periaortitis Demonstrated by FDG PET/CTMasatoshi Hotta, Go Naka, Ryogo Minamimoto, et al.
Asia Oceania Journal of Nuclear Medicine & Biology|July 14, 2016
Detection of prostate cancer by an FDG-PET cancer screening program: results from a Japanese nationwide surveyRyogo Minamimoto, Michio Senda, Seishi Jinnouchi, et al.
Clinical Nuclear Medicine|March 15, 2018
11C-4DST PET/CT Imaging of Cardiac Sarcoidosis: Comparison With 18F-FDG and Cardiac MRIMasatoshi Hotta, Ryogo Minamimoto, Shuji Kubota, et al.
Annals of Nuclear Medicine|November 11, 2020
Current status of radioligand therapy and positron-emission tomography with prostate-specific membrane antigenMasayuki Inubushi, Hiroyuki Miura, Ichiei Kuji, et al.
European Radiology|March 16, 2019
Impact of a modified peritoneal cancer index using FDG-PET/CT (PET-PCI) in predicting tumor grade and progression-free survival in patients with pseudomyxoma peritoneiMasatoshi Hotta, Ryogo Minamimoto, Yoshimasa Gohda, et al.
Plos One|April 29, 2016
Prognostic Value of Quantitative Metabolic Metrics on Baseline Pre-Sunitinib FDG PET/CT in Advanced Renal Cell CarcinomaRyogo Minamimoto, Amir Barkhodari, Lauren Harshman, et al.
Clinical Nuclear Medicine|June 21, 2017
Improved 123I-Ioflupane Binding After Immunotherapy in Anti-NAE Antibody-Positive Hashimoto Encephalopathy That Clinically Mimicked Multiple System AtrophyJuuri Otsuka, Ayumi Hida, Kamiyu Ogyu, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 31, 2018
Diagnostic performance of <sup>18</sup>F-FDG PET/CT using point spread function reconstruction on initial staging of rectal cancer: a comparison study with conventional PET/CT and pelvic MRIMasatoshi Hotta, Ryogo Minamimoto, Hideaki Yano, et al.
Clinical Nuclear Medicine|September 18, 2018
FDG PET/CT Findings in TAFRO SyndromeMasatoshi Hotta, Ryogo Minamimoto, Arisa Yashima, et al.
Pageof 15

Showing results (21-30 of 148) with videos related to

Sort By:
Pageof 15
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2016
Bombesin-Targeted PET of Prostate CancerRosalba Mansi, Ryogo Minamimoto, Helmut Mäcke, et al.
Clinical Nuclear Medicine|July 24, 2020
Nivolumab-Induced Periaortitis Demonstrated by FDG PET/CTMasatoshi Hotta, Go Naka, Ryogo Minamimoto, et al.
Asia Oceania Journal of Nuclear Medicine & Biology|July 14, 2016
Detection of prostate cancer by an FDG-PET cancer screening program: results from a Japanese nationwide surveyRyogo Minamimoto, Michio Senda, Seishi Jinnouchi, et al.
Clinical Nuclear Medicine|March 15, 2018
11C-4DST PET/CT Imaging of Cardiac Sarcoidosis: Comparison With 18F-FDG and Cardiac MRIMasatoshi Hotta, Ryogo Minamimoto, Shuji Kubota, et al.
Annals of Nuclear Medicine|November 11, 2020
Current status of radioligand therapy and positron-emission tomography with prostate-specific membrane antigenMasayuki Inubushi, Hiroyuki Miura, Ichiei Kuji, et al.
European Radiology|March 16, 2019
Impact of a modified peritoneal cancer index using FDG-PET/CT (PET-PCI) in predicting tumor grade and progression-free survival in patients with pseudomyxoma peritoneiMasatoshi Hotta, Ryogo Minamimoto, Yoshimasa Gohda, et al.
Plos One|April 29, 2016
Prognostic Value of Quantitative Metabolic Metrics on Baseline Pre-Sunitinib FDG PET/CT in Advanced Renal Cell CarcinomaRyogo Minamimoto, Amir Barkhodari, Lauren Harshman, et al.
Clinical Nuclear Medicine|June 21, 2017
Improved 123I-Ioflupane Binding After Immunotherapy in Anti-NAE Antibody-Positive Hashimoto Encephalopathy That Clinically Mimicked Multiple System AtrophyJuuri Otsuka, Ayumi Hida, Kamiyu Ogyu, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 31, 2018
Diagnostic performance of <sup>18</sup>F-FDG PET/CT using point spread function reconstruction on initial staging of rectal cancer: a comparison study with conventional PET/CT and pelvic MRIMasatoshi Hotta, Ryogo Minamimoto, Hideaki Yano, et al.
Clinical Nuclear Medicine|September 18, 2018
FDG PET/CT Findings in TAFRO SyndromeMasatoshi Hotta, Ryogo Minamimoto, Arisa Yashima, et al.
Pageof 15